Dear Doctor - Participate in the Survey on hepatitis of unknown etiology " A recent survey of hepatitis cases of unknown etiology in children found that the vast majority of cases were in infants under the age of 6 months. The most common symptoms reported were fever, diarrhea, and vomiting. However, a small number of children also had jaundice and liver enzymes that were elevated. The most common tests used to diagnose hepatitis are the alanine aminotransferase (ALT) test and the aspartate aminotransferase (AST) test. These tests can be used to identify liver damage and determine the cause of the hepatitis. In some cases, additional testing, such as a viral load test or a liver biopsy, may be needed to confirm the diagnosis. Treatment for hepatitis usually involves supportive care, such as rest and fluids, and may also include medications to reduce liver inflammation or suppress the immune system. Participate in Surveys "
1.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
2.
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?
3.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
4.
The pandemic had little impact on mental health symptoms.
5.
Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
1.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
2.
AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data
3.
Understanding the Rare Disease: Werner Syndrome Explained
4.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
5.
Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation